← Leaderboards
Joel Joseph Gagnier
University Of Michigan At Ann Arbor
$1,538,976
Attributed
$4,271,072
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,271,072 · 3
By mechanism
U01$3,579,362 · 1
R21$417,150 · 1
R34$274,560 · 1
Top collaborators
- Kevin Foxman Boehnke5 shared
- Chad M Brummett3 shared
- Hal Morgenstern2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Kevin Foxman Boehnke$1,899,756
- Thomas G Robins$10,229,414
- Renny T Franceschi$12,495,585
- John R Traynor$25,558,598
- Steven Edward Harte$6,619,782
Others in their field
Top investigators on “Systematic Review”
- Mary L. Disis · University Of Washington$47,475,880
- David Burch · Icf, Inc., Llc$41,028,720
- Philip J Weilerstein · Five Colleges Inc$40,841,977
- Kenneth C Anderson · Dana-Farber Cancer Inst$39,303,213
- Sean McSweeney · Brookhaven Science Assoc-Brookhaven Lab$29,388,179
- Walter John Curran · Thomas Jefferson University$26,641,549
Research focus
Systematic ReviewParticipantMeta-AnalysisEpidiolexDoseDouble-Blind MethodChronic PainControlled Clinical TrialsAcuteChronicClinical ResearchAcute PainAnxietyAmericanArthritisAnalgesicsAddictionClinical TrialsAnti-Anxiety AgentsCannabidiolCannabinoidsAnti-Inflammatory AgentsAffectCraving
Grant awards (7)
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty â a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)$1,109,271
U01 · FY2025 · AR
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty â a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)$1,194,710
U01 · FY2024 · AR
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty â a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)$1,275,381
U01 · FY2023 · AR
Planning Grant for a Clinical Trial Of Cannabidiol For Postoperative Opioid Reduction in Primary Total Knee Arthroplasty$68,640
R34 · FY2022 · AR
Planning Grant for a Clinical Trial Of Cannabidiol For Postoperative Opioid Reduction in Primary Total Knee Arthroplasty$205,920
R34 · FY2021 · AR
Development of guidelines for investigating heterogeneity in systematic reviews$185,400
R21 · FY2011 · LM · contact PI
Development of guidelines for investigating heterogeneity in systematic reviews$231,750
R21 · FY2010 · LM · contact PI